This results in: Fatigue Brain fog Slower healing At the core of this is mitochondrial dysfunction and oxidative stress
Image Credit: VectorMine / Shutterstock In a recent study published in the journal Frontiers in Pharmacology , researchers examined the potential role of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) in treating substance use disorders (SUDs)
Zheng H, Jiang L, Tsuduki T, Conrad M, Toyokuni S
Stimulating the central nervous system to promote long-lasting weight loss that doesnt depend solely on cutting calories is an intriguing idea, although the challenge will be finding an anti-obesity therapy that acts in that manner without negative side effects, said Isabelle Ct, Ph.D
Thats where IV therapy comes in: it delivers glutathione straight to your bloodstream for maximum absorption and results
What Are Your Options Now